122 related articles for article (PubMed ID: 30508038)
1. Targeting the centrosome and polo-like kinase 4 in osteosarcoma.
Kelleher FC; Kroes J; Lewin J
Carcinogenesis; 2019 Jun; 40(4):493-499. PubMed ID: 30508038
[TBL] [Abstract][Full Text] [Related]
2. Chronic centrosome amplification without tumorigenesis.
Vitre B; Holland AJ; Kulukian A; Shoshani O; Hirai M; Wang Y; Maldonado M; Cho T; Boubaker J; Swing DA; Tessarollo L; Evans SM; Fuchs E; Cleveland DW
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6321-30. PubMed ID: 26578792
[TBL] [Abstract][Full Text] [Related]
3. PLK4: a promising target for cancer therapy.
Zhao Y; Wang X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2413-2422. PubMed ID: 31492983
[TBL] [Abstract][Full Text] [Related]
4. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 as a potential therapeutic target for osteosarcoma.
Cheng L; Wang C; Jing J
Curr Pharm Des; 2015; 21(10):1347-50. PubMed ID: 25345614
[TBL] [Abstract][Full Text] [Related]
6. SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress.
Nakamura T; Saito H; Takekawa M
Nat Commun; 2013; 4():1775. PubMed ID: 23653187
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.
Kawakami M; Mustachio LM; Zheng L; Chen Y; Rodriguez-Canales J; Mino B; Kurie JM; Roszik J; Villalobos PA; Thu KL; Silvester J; Cescon DW; Wistuba II; Mak TW; Liu X; Dmitrovsky E
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1913-1918. PubMed ID: 29434041
[TBL] [Abstract][Full Text] [Related]
9. The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.
Holland AJ; Fachinetti D; Zhu Q; Bauer M; Verma IM; Nigg EA; Cleveland DW
Genes Dev; 2012 Dec; 26(24):2684-9. PubMed ID: 23249732
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review.
Shu Y; Liu Y; Bian S; Xie Z; Liao C
Mini Rev Med Chem; 2023; 23(1):67-79. PubMed ID: 35657046
[TBL] [Abstract][Full Text] [Related]
11. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells.
Meraldi P; Honda R; Nigg EA
EMBO J; 2002 Feb; 21(4):483-92. PubMed ID: 11847097
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
D'Assoro AB; Busby R; Suino K; Delva E; Almodovar-Mercado GJ; Johnson H; Folk C; Farrugia DJ; Vasile V; Stivala F; Salisbury JL
Oncogene; 2004 May; 23(23):4068-75. PubMed ID: 15064746
[TBL] [Abstract][Full Text] [Related]
13. Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis.
Serçin Ö; Larsimont JC; Karambelas AE; Marthiens V; Moers V; Boeckx B; Le Mercier M; Lambrechts D; Basto R; Blanpain C
Nat Cell Biol; 2016 Jan; 18(1):100-10. PubMed ID: 26595384
[TBL] [Abstract][Full Text] [Related]
14. Epidermal development, growth control, and homeostasis in the face of centrosome amplification.
Kulukian A; Holland AJ; Vitre B; Naik S; Cleveland DW; Fuchs E
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6311-20. PubMed ID: 26578791
[TBL] [Abstract][Full Text] [Related]
15. New molecular insights into osteosarcoma targeted therapy.
Yang J; Zhang W
Curr Opin Oncol; 2013 Jul; 25(4):398-406. PubMed ID: 23666471
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of targeting polo-like kinase 4.
Lei Q; Yu Q; Yang N; Xiao Z; Song C; Zhang R; Yang S; Liu Z; Deng H
Eur J Med Chem; 2024 Feb; 265():116115. PubMed ID: 38199166
[TBL] [Abstract][Full Text] [Related]
17. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
18. Centrosome Amplification Is Sufficient to Promote Spontaneous Tumorigenesis in Mammals.
Levine MS; Bakker B; Boeckx B; Moyett J; Lu J; Vitre B; Spierings DC; Lansdorp PM; Cleveland DW; Lambrechts D; Foijer F; Holland AJ
Dev Cell; 2017 Feb; 40(3):313-322.e5. PubMed ID: 28132847
[TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.
Chan CY; Yuen VW; Chiu DK; Goh CC; Thu KL; Cescon DW; Soria-Bretones I; Law CT; Cheu JW; Lee D; Tse AP; Tan KV; Zhang MS; Wong BP; Wong CM; Khong PL; Ng IO; Bray MR; Mak TW; Yau TC; Wong CC
Hepatology; 2023 Mar; 77(3):729-744. PubMed ID: 35302667
[TBL] [Abstract][Full Text] [Related]
20. S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells.
Ilisso CP; Sapio L; Delle Cave D; Illiano M; Spina A; Cacciapuoti G; Naviglio S; Porcelli M
J Cell Physiol; 2016 Feb; 231(2):428-35. PubMed ID: 26174106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
